1. Isanaka S; Guindo O; Langendorf C; Seck AM; Plikaytis BD; Sayinzoga-Makombe N; McNeal MM; Meyer N; Adehossi E; Djibo A. Efficacy of a Low-Cost, Heat-Stable Oral Rotavirus Vaccine in Niger. The New England journal of medicine. 2017; 376:1121-1130.
  2. Marigo I; Zilio S; Desantis G; Mlecnik B; Agnellini AHR; Ugel S; Sasso MS; Qualls JE; Kratochvill F; Zanovello P. T Cell Cancer Therapy Requires CD40-CD40L Activation of Tumor Necrosis Factor and Inducible Nitric-Oxide-Synthase-Producing Dendritic Cells. Cancer Cell. 2016; 30:377-390.
  3. Mohanty SK; Donnelly B; Lobeck I; Walther A; Dupree P; Coots A; Meller J; McNeal M; Sestak K; Tiao G. The SRL Peptide of Rhesus Rotavirus VP4 Protein Governs Cholangiocyte Infection and the Murine Model of Biliary Atresia. Hepatology. 2017; 65:1278-1292.
  4. Haslam DB. Nonalcoholic Steatohepatitis and the Intestinal Microbiota. Hepatology. 2017; 65:401-403.
  5. Lee S; Nguyen MT; Currier MG; Jenkins JB; Strobert EA; Kajon AE; Madan-Lala R; Bochkov YA; Gern JE; Roy K. A polyvalent inactivated rhinovirus vaccine is broadly immunogenic in rhesus macaques. Nature Communications. 2016; 7:12838.
  6. Hampton CM; Strauss JD; Ke Z; Dillard RS; Hammonds JE; Alonas E; Desai TM; Marin M; Storms RE; Leon F. Correlated fluorescence microscopy and cryo-electron tomography of virus- infected or transfected mammalian cells. Nature Protocols. 2017; 12:150-167.
  7. Payne DC; Sulemana I; Parashar UD; Curns AT; Esona MD; Mijatovic-Rustempasic S; Tate JE; Wikswo ME; Harrison CJ; Moffatt ME. Evaluation of effectiveness of mixed rotavirus vaccine course for rotavirus gastroenteritis. JAMA Pediatrics. 2016; 170:708-710.
  8. Cox JW; Ballweg RA; Taft DH; Velayutham P; Haslam DB; Porollo A. A fast and robust protocol for metataxonomic analysis using RNAseq data. Microbiome. 2017; 5:7.
  9. Kahn JA; Widdice LE; Ding L; Huang B; Brown DR; Franco EL; Bernstein DI. Substantial Decline in Vaccine-Type Human Papillomavirus (HPV) Among Vaccinated Young Women During the First 8 Years After HPV Vaccine Introduction in a Community. Clinical Infectious Diseases. 2016; 63:1281-1287.
  10. Navabi N; Whitt J; Wu SE; Woo V; Moncivaiz J; Jordan MB; Vallance BA; Way SS; Alenghat T. Epithelial Histone Deacetylase 3 Instructs Intestinal Immunity by Coordinating Local Lymphocyte Activation. Cell Reports. 2017; 19:1165-1175.
  11. Jiang TT; Martinov T; Xin L; Kinder JM; Spanier JA; Fife BT; Way SS. Programmed Death-1 Culls Peripheral Accumulation of High-Affinity Autoreactive CD4 T Cells to Protect against Autoimmunity. Cell Reports. 2016; 17:1783-1794.
  12. Johnson LR; Weizman OE; Rapp M; Way SS; Sun JC. Epitope-Specific Vaccination Limits Clonal Expansion of Heterologous Naive T Cells during Viral Challenge. Cell Reports. 2016; 17:636-644.
  13. Goldstein SL; Mottes T; Simpson K; Barclay C; Muething S; Haslam DB; Kirkendall ES. A sustained quality improvement program reduces nephrotoxic medication-associated acute kidney injury. Kidney international. 2016; 90:212-221.
  14. Hammonds JE; Beeman N; Ding L; Takushi S; Francis AC; Wang JJ; Melikyan GB; Spearman P. Siglec-1 initiates formation of the virus-containing compartment and enhances macrophage-to-T cell transmission of HIV-1. PLoS pathogens. 2017; 13:e1006181.
  15. Sawtell NM; Thompson RL. De Novo Herpes Simplex Virus VP16 Expression Gates a Dynamic Programmatic Transition and Sets the Latent/Lytic Balance during Acute Infection in Trigeminal Ganglia. PLoS pathogens. 2016; 12:e1005877.
  16. He Z; Liu B; Tao Y; Li C; Xia M; Zhong W; Jiang X; Liu H; Tan M. Norovirus GII.17 Natural Infections in Rhesus Monkeys, China. Emerging infectious diseases. 2017; 23:316-319.
  17. Bernstein DI; Wald A; Warren T; Fife K; Tyring S; Lee P; Van Wagoner N; Magaret A; Flechtner JB; Tasker S. Therapeutic vaccine for Genital herpes simplex virus-2 infection: Findings from a randomized trial. Journal of Infectious Diseases. 2017; 215:856-864.
  18. Kazi AM; Cortese MM; Yu Y; Lopman B; Morrow AL; Fleming JA; McNeal MM; Steele AD; Parashar UD; Zaidi AKM. Secretor and Salivary ABO Blood Group Antigen Status Predict Rotavirus Vaccine Take in Infants. Journal of Infectious Diseases. 2017; 215:786-789.
  19. Hoft DF; Lottenbach K; Goll JB; Hill H; Winokur PL; Patel SM; Brady RC; Chen WH; Edwards K; Creech CB. Priming Vaccination With Influenza Virus H5 Hemagglutinin Antigen Significantly Increases the Duration of T cell Responses Induced by a Heterologous H5 Booster Vaccination. Journal of Infectious Diseases. 2016; 214:1020-1029.
  20. Bowen MD; Mijatovic-Rustempasic S; Esona MD; Teel EN; Gautam R; Sturgeon M; Azimi PH; Baker CJ; Bernstein DI; Boom JA. Rotavirus Strain Trends During the Postlicensure Vaccine Era: United States, 2008-2013. Journal of Infectious Diseases. 2016; 214:732-738.
  21. Yu G; Li K; Huang P; Jiang X; Jiang W. Antibody-Based Affinity Cryoelectron Microscopy at 2.6-Å Resolution. Structure. 2016; 24:1984-1990.
  22. Yuan Z; Fan X; Staitieh B; Bedi C; Spearman P; Guidot DM; Sadikot RT. HIV-related proteins prolong macrophage survival through induction of Triggering receptor expressed on myeloid cells-1. Scientific Reports. 2017; 7:42028.
  23. Zhang XF; Long Y; Tan M; Zhang T; Huang Q; Jiang X; Tan WF; Li JD; Hu GF; Tang S. P[8] and P[4] Rotavirus Infection Associated with Secretor Phenotypes Among Children in South China. Scientific Reports. 2016; 6:34591.
  24. Xia M; Wei C; Wang L; Cao D; Meng XJ; Jiang X; Tan M. Development and evaluation of two subunit vaccine candidates containing antigens of hepatitis E virus, rotavirus, and astrovirus. Scientific Reports. 2016; 6:25735.
  25. Lei S; Ryu J; Wen K; Twitchell E; Bui T; Ramesh A; Weiss M; Li G; Samuel H; Clark-Deener S. Increased and prolonged human norovirus infection in RAG2/IL2RG deficient gnotobiotic pigs with severe combined immunodeficiency. Scientific Reports. 2016; 6:25222.